PYPD Company Profile and Key Details
NASDAQ : PYPD
PolyPid
$5.16
-0.04-0.77%
At Close 4:00 PMPrice Chart
Stock Price Today
PolyPid Ltd. (PYPD) stock declined over -0.77%, trading at $5.16 on NASDAQ, down from the previous close of $5.20. The stock opened at $5.25, fluctuating between $5.13 and $5.25 in the recent session.
Stock Snapshot
5.2
Prev. Close
98.47M
Market Cap
5.13
Day Low
-3.49
P/E Ratio
-1.48
EPS (TTM)
N/A
Cash Flow per Share
5.25
Open
19.08M
Number of Shares
5.245
Day High
N/A
Free Float in %
N/A
Book Value
69.57K
Volume
Relevant Articles
SEC Fillings
Current Report (8-k)
| Filing Date | Accepted Date | |
|---|---|---|
Annual Report (10-k)
| Filing Date | Accepted Date | |
|---|---|---|
Loading...
Contact Details
About Company
No Data
Company Information
| Employees | N/A |
| Beta | N/A |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | N/A |
| Industry | N/A |
Company Overview
PolyPid Ltd. (NASDAQ:PYPD) closed at $5.16 USD, losing -$0.04 (-0.77%) from the previous close of $5.20. The stock is currently mid-range between its 52-week high and low $3.06 and $5.73. With a market capitalization of about $98.47 million, PolyPid Ltd. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.42). Key stats such as the average daily volume over the past year has been around 215.81 thousand shares, volume is running light vs its 52-week average. Headquartered in Petah Tikva, HM, PolyPid Ltd. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Dikla Czaczkes Akselbrad, the company employs approximately 72 people and listed since June 26, 2020. PolyPid Ltd. is an advanced-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of therapeutic solutions.
Technical Performance
Short-term trend indicators are bearishly aligned (SMA20 -5.37%, SMA50 -4.25%, SMA200 14.35%). The stock’s 14-day RSI is 42.11 (neutral), while the ATR of 0.25 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -17.58% below its high and over 83.48% above its low. Average 10-day trading volume of 109.85 thousand shares is below the 3-month average of 209.98 thousand, indicating normal recent market interest.
Dividend & Fair Value
PolyPid Ltd. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.22. This means the shares are trading above this model’s fair value.
Earnings & Analyst Outlook
PolyPid Ltd. generated EPS of -$2.26 over the past year. Five-year average earnings growth is 14.14%. The latest quarter delivered EPS of -$0.35. The next quarter is forecast at -$0.43. Next year's EPS is expected at $16.17. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $13.00 to $9.00. The high target offers 151.94% upside. The low target suggests 74.42% downside. The mean target is $11.67. This offers 126.16% upside. PolyPid Ltd. earnings surprise history is a mixed track record. The quarter that ended August 12, 2026, missed forecasts by -7.28%. The prior quarter beat by -25.53%. Over the last six quarters, Apple has recorded several small beats. These include -12.5% in May 14, 2025.
Shareholding & Insider Activity
PolyPid Ltd. has 20.31 million shares outstanding. The public float is 12.16 million shares, elevated short interest at 2.94% of float. This equals 412.85 thousand shares. The short ratio is 1.25 days. Institutional investors hold 44.24% of the float. Insiders own 21.23%.
Financial & Profitability Overview
On valuation metrics, PYPD trades at a P/E of -3.49, P/S of 0.00 and P/B of 21.68. The current ratio is 1.35 and quick ratio is 1.14. Debt-to-equity is 0.29, supported by a cash flow-to-debt ratio of 0.00.
Price Forecast & Outlook
Our AI price prediction model suggests that PolyPid Ltd. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 7.95%, with price expected at $5.57 by September 24, 2026, within a range of $5.43 to $5.72 3-Month Outlook: Projected rise of 67.05%, reaching $8.62 by December 08, 2026, with a range of $8.47 to $8.78. 1-Year Outlook: Projected gain of 249.81%, with price at $18.05 by September 10, 2027, within a range of $7.44 to $27.13.
Frequently Asked Questions
What is the current undefined (PYPD) stock price?
(NASDAQ: PYPD) stock price is $5.16 in the last trading session. During the trading session, PYPD stock reached the peak price of $5.25 while $5.13 was the lowest point it dropped to. The percentage change in PYPD stock occurred in the recent session was -0.77% while the dollar amount for the price change in PYPD stock was - $0.04.
PYPD's industry and sector of operation?
The NASDAQ listed PYPD is part of industry that operates in the broader sector. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Who are the executives of PYPD?
No Data
How PYPD did perform over past 52-week?
PYPD's closing price is N/A higher than its 52-week low of $3.06 where as its distance from 52-week high of $5.73 is N/A.
How many employees does PYPD have?
Number of PYPD employees currently stands at NaN.
How do I contact PYPD?
How many shares of PYPD are traded daily?
PYPD stock volume for the day was 69.57K shares. The average number of PYPD shares traded daily for last 3 months was 215.81K.
What is the market cap of PYPD currently?
The market value of PYPD currently stands at $98.47M with its latest stock price at $5.16 and 19.08M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep